Artemisinin derivatives versus quinine for cerebral malaria in African children: A systematic review

Bulletin of the World Health Organization

Volumn 87, Issue 12, 2009, Pages 896-905

  Kyu, Hmwe Hmwe ^a   Fernández, Eduardo ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEETHER; ARTEMETHER; QUININE;

CHILD HEALTH; COMPARATIVE STUDY; DRUG; MALARIA; QUININE; STATISTICAL ANALYSIS;

ABSCESS; AFRICA; BLACK WATER FEVER; BRAIN MALARIA; CLINICAL TRIAL; COCHRANE LIBRARY; CONFIDENCE INTERVAL; DRUG EFFICACY; EMBASE; FEVER; HUMAN; HYPOGLYCEMIA; INJECTION SITE REACTION; MEDLINE; MORTALITY; QT PROLONGATION; REVIEW; RISK FACTOR; SYSTEMATIC REVIEW; URTICARIA; VOMITING;

AFRICA; ANTI-INFECTIVE AGENTS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; INFANT; MALARIA, CEREBRAL; MALE; OUTCOME ASSESSMENT (HEALTH CARE); QUININE;

EID: 72049098823     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.08.060327     Document Type: Review

References (29)

1. Roll Back Malaria Partners set ambitious financial targets for 19 African countries fighting malaria. Geneva: World Health Organization; 2007. Available from: http://www.rollbackmalaria.org/amd2007/pr/pr-rbmAMD2007-e.pdf. [accessed on 6 August 6 2008].
2. Management of severe malaria. 2nd ed. Geneva: World Health Organization; 2000.
3. Jaffar S, Van Hensbroek MB, Palmer A, Schneider G, Greenwood B. Predictors of a fatal outcome following childhood cerebral malaria. Am J Trop Med Hyg 1997;57:20-24 PMID:9242312 (Pubitemid 27305177)
4. Severe and complicated malaria. Trans R Soc Trop Med Hyg 1990;84 Suppl 2;1-65. doi:10.1016/0035-9203(90)90363-J
5. Looareesuwan S, Oosterhuis B, Schilizzi BM, Sollie FA, Wilairatana P, Krudsood S, et al. Dose-finding and efficacy study for i.m. artemotil (beta-arteether) and comparison with i.m. artemether in acute uncomplicated P. falciparum malaria. Br J Clin Pharmacol 2002;53:492-500. doi:10.1046/j.1365- 2125.2002.01590.x PMID:11994055 (Pubitemid 34526501)
6. WHO Informal consultation on clinical neurological investigations required for patients treated with artemisinin compounds and derivatives: report of an informal consultation convened by WHO. Geneva: World Health Organization; 1998 (TDR/TDF/99.1).
7. Malaria. National Malaria Control Programme Managers. Current malaria situation and trends. Geneva: World Health Organization; 2007. Available from: http://www.searo.who.int/en/Section10/Section21/Section342-1023.htm [accessed on 6 August 2008].
8. Mutanda LN. Assessment of drug resistance to the malaria parasite in residents of Kampala, Uganda. East Afr Med J 1999;76:421-424 PMID:10520345
9. Facts on ACTs (artemisinin-based combination therapies). Geneva: World Health Organization; 2006. Available from: http://www.rbm.who.int/cmc-upload/0/ 000/015/364/RBMInfosheet-9.htm [accessed on 5 August 2008].
10. WHO. Resistance to artemisinin derivatives along the Thai-Cambodian border. Wkly Epidemiol Rec 2007;82:360. PMID:17933087
11. Lugt CB. Dutch registration for artemotil injections. TDR News 2000;63. Available from: http://www.who.int/tdr/publications/tdrnews/news63/artemotil.htm [accessed on 20 July 2008].
12. Artemether-Quinine Meta-analysis Study Group. A meta-analysis using individual patient data of trials comparing artemether with quinine in the treatment of severe falciparum malaria. Trans R Soc Trop Med Hyg 2001;95:637-650 doi:10.1016/S0035-9203(01)90104-X PMID:11816438
13. Afolabi BB, Okoromah CAN. Intramuscular arteether for treating severe malaria. Cochrane Database Syst Rev 2004;18:CD004391.
14. Cochrane Infectious Diseases Group. Guide to preparing and using the 'Methods of the review'. Liverpool, England: Cochrane; 2005. Available from: http://www.liv.ac.uk/evidence/CIDG/methods-guide.htm [accessed on 21 March 2008].
15. Jüni P, Altman DG, Egger M. Systematic reviews in health care: Assessing the quality of controlled clinical trials. BMJ 2001;323:42-46 doi:10.1136/bmj.323.7303.42 PMID:11440947 (Pubitemid 32682008)
16. Daya S. Funnel plots and publication bias-work in progress? Evidence-based. Obstet Gynecol 2006;8:71-72 (Pubitemid 44734492)
17. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analysis. BMJ 2003;327:557-560 doi:10.1136/bmj.327.7414.557 PMID:12958120
18. Aceng JR, Byarugaba JS, Tumwine JK. Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: randomised clinical trial. BMJ 2005;330:334. doi:10.1136/bmj.330.7487.334 PMID:15705690
19. Olumese PE, Bjorkman A, Gbadegesin RA, Adeyemo AA, Walker O. Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria. Acta Trop 1999;73:231-236 doi:10.1016/S0001- 706X(99)00031-5 PMID:10546840 (Pubitemid 29528113)
20. Murphy S, English M, Waruiru C, Mwangi I, Amukoye E, Crawley J, et al. An open randomized trial of artemether versus quinine in the treatment of cerebral malaria in African children. Trans R Soc Trop Med Hyg 1996;90:298-301. doi:10.1016/S0035-9203(96)90260-6 PMID:8758084 (Pubitemid 26189112)
21. Ojuawo A, Adegboye AR, Oyewale O. Clinical response and parasite clearance in childhood cerebral malaria: A comparison between intramuscular artemether and intravenous quinine. East Afr Med J 1998;75:450-452 (Pubitemid 128386097)
22. Van Hensbroek MB, Onyiorah E, Jaffar S, Schneider G, Palmer A, Frenkel J, et al. A trial of artemether or quinine in children with cerebral malaria. N Engl J Med 1996;335:69-75. doi:10.1056/NEJM199607113350201 PMID:8649492 (Pubitemid 26240107)
23. Taylor TE, Wills BA, Courval JM, Molyneux ME. Intramuscular artemether vs intravenous quinine: an open, randomized trial in Malawian children with cerebral malaria. Trop Med Int Health 1998;3:3-8. doi:10.1046/j.1365-3156.1998. 00166.x PMID:9484961 (Pubitemid 28081012)
24. Satti GM, Elhassan SH, Ibrahim SA. The efficacy of artemether versus quinine in the treatment of cerebral malaria. J Egypt Soc Parasitol 2002;32:611-623 PMID:12214938
25. Thuma PE, Bhat GJ, Mabeza GF, Osborne C, Biemba G, Shakankale GM, et al. A randomized controlled trial of artemotil (beta-arteether) in Zambian children with cerebral malaria. Am J Trop Med Hyg 2000;62:524-529 PMID:11220772 (Pubitemid 32164764)
26. Moyou-Somo R, Tietche F, Ondoa M, Kouemeni LE, Ekoe T, Mbonda E, et al. Clinical trial of beta-arteether versus quinine for the treatment of cerebral malaria in children in Yaounde, Cameroon. Am J Trop Med Hyg 2001;64:229-232 PMID:11463108 (Pubitemid 32652417)
27. Schünemann HJ, Jaeschke R, Cook DJ, Bria WF, El-Solh AA, Ernst A, et al. An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations. Am J Respir Crit Care Med 2006;174:605-614 doi:10.1164/rccm.200602-197ST PMID:16931644 (Pubitemid 44330555)
28. Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 2005;5:13. doi:10.1186/1471-2288-5-13 PMID:15840177 (Pubitemid 40923590)
29. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.1 [updated September 2008]. Section. 7.7.3.5 Medians and interquartile ranges. The Cochrane Collaboration, 2008. Available at: www.cochranehandbook.org [accessed 14 March 2009].